meropenem injection doseMuses
MEROPENEM MYLAN 1 g, poudre pour solution injectable/pour perfusion vous sera administré en injection ou en perfusion dans une grosse veine. Table 1: Recommended Meropenem for Injection Dosage Schedule for Adult Patients with Renal Impairment. No dose adjustment is required for the elderly with normal renal function or creatinine clearance values above 50 ml/min. Solutions prepared for infusion (meropenem for injection concentrations ranging from 1 mg/mL to 20 mg/mL) re-constituted with Dextrose Injection 5% should be used immediately. The following For the best effect, use this antibiotic at evenly spaced times. When treating infections caused by, 1 gram every 8 hours by intravenous infusion over 15 minutes to 30 minutes for intra-abdominal infections for adult patients. Provided meropenem injection is used to treat infections such as bacterial meningitis. Cross-resistance is sometimes observed with isolates resistant to other carbapenems. resistant to other antibiotics. (2.3), Pediatric patients less than 3 months of age, Recommended Meropenem for Injection Dosage Schedule for Pediatric Patients Less than 3 Months of Age with Complicated Intra-Abdominal Infections and Normal Renal Function (2.3), Infants less than 32 weeks GA and PNA less than 2 weeks, Infants less than 32 weeks GA and PNA 2 weeks and older, Infants 32 weeks and older GA and PNA less than 2 weeks, Infants 32 weeks and older GA and PNA 2 weeks and older. Discard unused portion. In vitro tests show meropenem to act synergistically with aminoglycoside antibacterial drugs against some isolates of A positive direct or indirect Coombs test may develop during treatment with meropenem. (, 500 mg every 8 hours by intravenous infusion over 15 to 30 minutes for complicated skin and skin structure infections (cSSSI) for adult patients. Meropenem for injection, like all β-lactam antibiotics, has the potential to cause seizures. Currently there is no additional information available to further interpret this observation. Limited postmarketing experience indicates that if adverse events occur following overdosage, they are consistent with the adverse event profile described in the Adverse Reactions section and are generally mild in severity and resolve on withdrawal or dose reduction. Get Label RSS Feed, 2O with a molecular weight of 437.52. If you are a consumer or patient please visit Skin reactions. Sodium content is 45.1 mg (1.96 mEq). 72572-416-01, For a full list of excipients, see section 6.1. Dosage and Administration (2.3), There was no evidence of mutagenic potential in a conventional test battery and no evidence of reproductive toxicity including teratogenic potential in studies in rats up to 750 mg/kg and in monkeys up to 360 mg/kg. Pseudomonas aeruginosa. No dose adjustment is necessary in patients with hepatic impairment (see section 4.4). The potential effect of meropenem on the protein binding of other medicinal products or metabolism has not been studied. Meropenem concentrations in the CSF of children with meningitis are approximately 20 % of concurrent plasma levels although there is significant inter-individual variability. When meropenem for injection is prescribed to treat a bacterial infection, tell patients that although it is common to feel better early in the course of therapy, take the medication exactly as directed. Meropenem for injection, like all β-lactam antibiotics, has the potential to cause seizures. Intravenous infusions over 2 minutes, 3 minutes and 5 minutes of a 1 g dose of meropenem were compared in a three way crossover trial. 25N Staphylococcus aureus (MRSA) or methicillin-resistant Meropenem is primarily excreted unchanged by the kidneys; approximately 70 % (50 –75 %) of the dose is excreted unchanged within 12 hours. Hypersensitivity to any other carbapenem antibacterial agent. In vitro meropenem shows reduced susceptibility to hydrolysis by human dehydropeptidase-I (DHP-I) compared to imipenem and there is no requirement to co-administer a DHP-I inhibitor. To prevent unintentional overdose, this product should not be used in pediatric patients who require less than the full adult dose of meropenem. Meropenem may also be used for purposes not listed in this medication guide. in vitro and animal studies suggest that carbapenems may inhibit the hydrolysis of valproic acid's glucuronide metabolite (VPA-g) back to valproic acid, thus decreasing the serum concentrations of valproic acid. Meropenem has been shown to penetrate well into several body fluids and tissues: including lung, bronchial secretions, bile, cerebrospinal fluid, gynaecological tissues, skin, fascia, muscle, and peritoneal exudates. ), the highest mean concentrations of meropenem were found in tissues and fluids at 1 hour (0.5 hours to 1.5 hours) after the start of infusion, except where indicated in the tissues and fluids listed in Table 5 below. Patients who have a history of hypersensitivity to carbapenems, penicillins or other beta-lactam antibiotics may also be hypersensitive to meropenem. Warnings and Precautions (5.4)]. The measured renal clearance and the effect of probenecid show that meropenem undergoes both filtration and tubular secretion. Each vial contains meropenem equivalent to 500 mg of meropenem activity. A five minute intravenous bolus injection of meropenem in normal volunteers results in peak plasma levels of approximately 52 microgram/mL for the 500 mg dose and 112 microgram/mL for the 1 g dose. The pharmacokinetics in infants and children with infection at doses of 10, 20 and 40 mg/kg showed Cmax values approximating to those in adults following 500, 1000 and 2000 mg doses, respectively. In subjects with normal renal function, the elimination half-life of meropenem is approximately 1 hour. [see eosinophilia, thrombocytopenia, leucopenia, neutropenia, agranulocytosis, haemolytic anaemia. Concomitant use with valproic acid/sodium valproate/valpromide. However, the protein binding is so low that no interactions with other compounds would be expected on the basis of this mechanism. Clinical Pharmacology (12.3), Meropenem is cleared by haemodialysis with clearance during haemodialysis being approximately 4 times higher than in anuric patients. A solution for bolus injection is prepared by dissolving the drug product meropenem in sterile water for injection to a final concentration of 50 mg/ml. Among these are included prior history of seizures or CNS abnormality and concomitant medications with seizure potential. - Intravenous bolus injection (5 mL to 20 mL) is to be given over approximately 3 minutes to 5 minutes. No accumulation of meropenem in plasma was observed with regimens using 500 mg administered every 8 hours or 1 gram administered every 6 hours in healthy volunteers with normal renal function. Case reports in the literature have shown that co-administration of carbapenems, including meropenem, to patients receiving valproic acid or divalproex sodium results in a reduction in valproic acid concentrations. The following are discussed in greater detail in other sections of labeling: Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Meropenem 500 MG Injection is a broad spectrum antibiotic used to treat a variety of conditions caused by bacteria such as infections of stomach, brain, and lungs. Pharmacokinetic/Pharmacodynamic (PK/PD) relationship. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Meropenem for injection is indicated for the treatment of complicated skin and skin structure infections (cSSSI) due to Qualitative and quantitative composition, 4.2 Posology and method of administration, 4.4 Special warnings and precautions for use, 4.5 Interaction with other medicinal products and other forms of interaction, 4.7 Effects on ability to drive and use machines, 6.6 Special precautions for disposal and other handling, 9. It is given by injection into a vein.. Common side effects include nausea, diarrhea, constipation, headache, rash, and pain at the site of injection. However, there is no information on the usefulness of hemodialysis to treat overdosage Re-constitute injection vials (500 mg and 1 gram) with sterile Water for Injection (see dosing Table 3 below. resistant to other antibiotics. . C. difficile produces toxins A and B which contribute to the development of CDAD. Meropenem, sold under the brandname Merrem among others, is a broad-spectrum antibiotic used to treat a variety of bacterial infections. Meropenem for Injection Page 6 of 36 Meropenem for Injection, like all β-lactam antibiotics, has the potential to cause seizures. The current US Food and Drug Administration (FDA)‐recommended meropenem dosing regimens for pediatric patients with severe systemic and intra‐abdominal infections were derived from a series of PK and PD studies 1, 9, 10 and are outlined in Table 1. No dose adjustment is required in elderly patients, except in cases of moderate to severe renal impairment (see section 4.2). However, bacteria may exhibit resistance to more than one class of antibacterials agents when the mechanism involved include impermeability and/or an efflux pump(s). Meropenem - Injection. Includes dosages for Skin and Structure Infection, Intraabdominal Infection, Nosocomial Pneumonia and more; plus renal, liver and dialysis adjustments. Counsel patients that diarrhea is a common problem caused by antibacterial drugs which usually ends when the antibacterial drug is discontinued. Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). Diminished renal function and central nervous system lesions may increase the risk of seizures. There is no target-based cross-resistance between meropenem and agents of the quinolone, aminoglycoside, macrolide and tetracycline classes. [see The clinical response rate in LRTI at end of therapy was 93% for meropenem 500 mg tds, compared with 92% for ceftazidime 1 g tds; for meropenem 500 mg bd the clinical response rate was 96%, compared with 91% for imipenem/cilastatin 500 mg bd (P = 0.054). Decreases in blood levels of valproic acid have been reported when it is co-administered with carbapenem agents resulting in a 60-100 % decrease in valproic acid levels in about two days. oC to 25 Meropenem, sold under the brandname Merrem among others, is a broad-spectrum antibiotic used to treat a variety of bacterial infections. Case reports in the literature have shown that co-administration of carbapenems, including meropenem, to patients receiving valproic acid or divalproex sodium results in a reduction in valproic acid concentrations. Before initiating therapy with meropenem, careful inquiry should be made concerning previous hypersensitivity reactions to beta-lactam antibiotics. Simultaneous administration of antibiotics with warfarin may augment its anti-coagulant effects. Deaths in 5 patients were assessed as possibly related to meropenem; 36 (1.2%) patients had meropenem discontinued because of adverse events. Antibacterial drugs other than carbapenems should be considered to treat infections in patients whose seizures are well controlled on valproic acid or divalproex sodium. Severe pneumonia including hospital and ventilator-associated pneumonia. Dosage and Administration (2.4)]. C. difficile, and surgical evaluation should be instituted as clinically indicated. [see Hypertoxin producing isolates of The dose for adults and adolescents should be adjusted when creatinine clearance is less than 51 ml/min, as shown below. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. Genetic toxicity studies were performed with meropenem using the bacterial reverse mutation test, the Chinese hamster ovary HGPRT assay, cultured human lymphocytes cytogenic assay, and the mouse micronucleus test. The values represent the number of patients clinically cured/number of clinically evaluable patients, with the percent cure in parentheses. When meropenem for injection is indicated in patients with these risk factors, caution is advised. Abdominal pain. The solution varies from colorless to yellow depending on the concentration. Histological evidence of renal tubular damage was seen in mice and dogs only at doses of 2000 mg/kg and above after a single administration and above and in monkeys at 500 mg/kg in a 7-day study. Use half normal dose every 24 hours if eGFR less than 10 mL/minute/1.73 m 2. The selection of meropenem to treat an individual patient should take into account the appropriateness of using a carbapenem antibacterial agent based on factors such as severity of the infection, the prevalence of resistance to other suitable antibacterial agents and the risk of selecting for carbapenem-resistant bacteria. We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. Meropenem injection is in a class of medications called antibiotics. If you have any questions, ask your doctor or pharmacist. A solution for bolus injection is prepared by dissolving the drug product meropenem in sterile water for injection to a final concentration of 50 mg/ml. Meropenem is known to be substantially excreted by the kidney, and the risk of adverse reactions to this drug may be greater in patients with renal impairment. Renal function - increase dose interval in renal failure. Approximately 60 % of the dose is excreted in urine over 12 hours as meropenem with a further 12 % as metabolite. There are limited safety data available to support the administration of a 2 g dose in adults as an intravenous bolus injection. To view updated drug label links, paste the RSS feed address (URL) shown below into a RSS reader, or use a browser which supports RSS feeds, such as Safari for Mac OS X. Increasing the dose of valproic acid or divalproex sodium may not be sufficient to overcome this interaction. Meropenem readily penetrates the cell wall of most Gram-positive and Gram-negative bacteria to reach penicillin-binding- protein (PBP) targets. Pediatric Patients Less Than 3 Months of Age. dose Every 24 hours Meropenem for Injection and Sodium Chloride Injection in the DUPLEX® Container is designed to deliver a 500 mg or 1 gram dose of Meropenem. The largest dose of meropenem administered in clinical trials has been 2 grams given intravenously every 8 hours. Single dose clear glass vials of meropenem for injection containing 500 mg or 1 gram (as the trihydrate blended with anhydrous sodium carbonate for re-constitution) of sterile meropenem powder. Date of first authorisation/renewal of the authorisation. Warnings and Precautions (5.3), 17H Second generation offspring showed no meropenem-related effects. The sole metabolite of meropenem had a similar profile of toxicity in animal studies. Some of these include meningitis, intra-abdominal infection, pneumonia, sepsis, and anthrax. 4F, No. Resistance to penems of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. †Resistance rate ≥ 50% in one or more EU countries. Know Meropenem 500 MG Injection uses, side-effects, composition, substitutes, drug interactions, precautions, dosage, warnings only on Lybrate.com Viridans group streptococci. Dosage and Administration (2.3), Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. [see Treating physicians should refer to national and/or international consensus documents regarding the treatment of glanders and melioidosis. If this occurs, patients should contact their physician as soon as possible, Counsel patients to inform their physician if they are taking valproic acid or divalproex sodium. Dose adjustment is recommended for patients with moderate and severe renal impairment (see section 4.2). Dosage should be reduced in adult patients with renal impairment. Meropenem 500 mg: This medicinal product contains approximately 2.0 mEq of sodium per 500 mg dose which should be taken into consideration by patients on a controlled sodium diet. In fertility studies, intravenous meropenem was administered to male rats beginning 11 weeks before mating and throughout mating and to female rats from 2 weeks before mating through Gestation Day 7 at doses of 240, 500, and 1000 mg/kg/day. in vitro activity against methicillin-resistant The pharmacokinetics of meropenem for injection I.V., in pediatric patients 2 years of age or older, are similar to those in adults. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. There is no evidence of an increased risk of any adverse drug reaction in children based on the limited available data. transaminases increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased. Dosage and Administration (2.2), When multiple doses are administered 8-hourly to subjects with normal renal function, accumulation of meropenem does not occur. Drug Interactions (7.2)]. The pharmacokinetics of meropenem, in pediatric patients 2 years of age or older, are similar to those in adults. October 28, 2020. 8 hours (maximum dose is 2 grams every 8 hours), depending on the type of infection (cSSSI, cIAI, intra-abdominal infection or meningitis). The study was open-label, uncontrolled, 98% of the infants received concomitant medications, and the majority of adverse events were reported in neonates less than 32 weeks gestational age and critically ill at baseline, making it difficult to assess the relationship of the adverse events to meropenem. Meropenem is also used to treat bacterial meningitis (infection of brain or spinal cord). For IV Preparation: Dilute with approved diluent and prepare as specified in the package insert. C. difficile. Discontinuation of therapy with meropenem and the administration of specific treatment for Clostridium difficile should be considered. in vitro and in clinical infections For 2 g (1 g meropenem and 1 g vaborbactam) dose, use an … Adverse Reactions(6.2)]. Meropenem Injection 500MG Meropenem is used to treat severe infections of the skin or stomach. Meropenem is not licensed for children <3 months of age. Neisseria meningitidis and penicillin-susceptible isolates of Streptococcus pneumoniae. Citations, 1.1 Complicated Skin and Skin Structure Infections (Adult Patients and Pediatric Patients 3 Months of Age and Older Only), 1.2 Complicated Intra-abdominal Infections (Adult and Pediatric Patients), 1.3 Bacterial Meningitis (Pediatric Patients 3 Months of Age and Older Only), 2.2 Use in Adult Patients with Renal Impairment, 2.4 Preparation and Administration of Meropenem for Injection, 5.4 Risk of Breakthrough Seizures Due to Drug Interaction with Valproic Acid, 5.5 Clostridium difficile-associated Diarrhea, 5.6 Development of Drug-Resistant Bacteria, 5.7 Overgrowth of Nonsusceptible Organisms, 6.1 Adverse Reactions from Clinical Trials, 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility, 14.1 Complicated Skin and Skin Structure Infections, 14.2 Complicated Intra-Abdominal Infections, PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton, PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton, PRINCIPAL DISPLAY PANEL - 500 mg Vial Label, PRINCIPAL DISPLAY PANEL - 1 gram Vial Label, Report Adverse Co-administration of probenecid with meropenem is not recommended. Meropenem administered intravenously to pregnant Cynomolgus monkeys during organogenesis from Day 20 to 50 after mating at doses of 120, 240, and 360 mg/kg/day did not produce maternal or fetal toxicity at the NOAEL dose of 360 mg/kg/day (approximately 2.3 times the MRHD based on body surface area comparison). Haemophilus influenzae, Meropenem is also used to treat bacterial meningitis (infection of brain or spinal cord). A 5-minute intravenous bolus injection of MERREM IV in healthy volunteers results in mean peak plasma concentrations of approximately 45 mcg/mL (range 18-65) for the 500 mg dose and 112 mcg/mL (range 83-140) for the 1 gram dose. penicillins or cephalosporins). The dosage is based on your medical condition and response to treatment. The most common adverse events occurring in greater than 5% of the patients were: headache (7.8%), nausea (7.8%), constipation (7.0%), diarrhea (7.0%), anemia (5.5%), and pain (5.1%). Limited post-marketing experience indicates that if adverse reactions occur following overdose, they are consistent with the adverse reaction profile described in section 4.8, are generally mild in severity and resolve on withdrawal or dose reduction. Events, This medication is given by injection into a vein as directed by your doctor, usually every 8 hours. A comparable number of patients were found to be clinically evaluable (ranging from 61-68%) and with a similar distribution of pathogens isolated on initial CSF culture. Compatibility of meropenem for injection with other drugs has not been established. See (, For pediatric patients 3 months of age and older, the meropenem for injection dose is 10 mg/kg, 20 mg/kg or 40 mg/kg every 8 hours (maximum dose is 2 grams every 8 hours), depending on the type of infection (cSSSI, cIAI, intra-abdominal infection or meningitis). Meropenem readily penetrates the cell wall of most Gram-positive and Gram-negative bacteria to reach penicillin-binding- protein (PBP) targets. Dosage adjustments are necessary in subjects with renal impairment (creatinine clearance 50 mL/min or less) In healthy subjects the mean plasma half-life is approximately 1 hour; the mean volume of distribution is approximately 0.25 l/kg (11-27 l) and the mean clearance is 287 ml/min at 250 mg falling to 205 ml/min at 2 g. Doses of 500, 1000 and 2000 mg doses infused over 30 minutes give mean Cmax values of approximately 23, 49 and 115 µg/ml respectively, corresponding AUC values were 39.3, 62.3 and 153 µg.h/ml. Listeria monocytogenes, against which lethal activity is not observed. In the table below all adverse reactions are listed by system organ class and frequency: very common (≥ 1/10); common (≥ 1/100 to <1/10); uncommon (≥ 1/1,000 to <1/100); rare (≥ 1/10,000 to <1/1,000); very rare (< 1/10,000) Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Staphylococcus aureus (methicillin-susceptible isolates only) Streptococcus agalactiae Dosage adjustment is recommended in patients with advanced age and/or adult patients with creatinine clearance of 50 mL/min or less When meropenem for injection is indicated in patients with these risk factors, caution is advised. Small amounts of meropenem have been reported to be excreted in human milk. For intravenous infusion, meropenem vials may be directly constituted with 0.9 % sodium chloride or 5% glucose solutions for infusion. Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. In individuals with normal renal function, rapid renal elimination takes place. Higher doses (40 mg/kg/dose IV every 8 hours) have been used in patients with severe infections. Table 8: Clinical Efficacy Rates by Pathogen for Clinically Evaluable Population. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate sent to a reference laboratory. Prior to Constitution: Store at 20 Meropenem 500 MG Injection is used for Bacterial Meningitis, Skin And Structure Infection, Intra-Abdominal Infections etc. Dosage and Administration (2.3), In a review of 4,872 patients with 5,026 meropenem treatment exposures, meropenem-related adverse reactions most frequently reported were diarrhoea (2.3 %), rash (1.4 %), nausea/vomiting (1.4 %) and injection site inflammation (1.1 %). 3Susceptibility of staphylococci to Carbepenem is inferred from the cefoxitinsusceptibility. Clinical Pharmacology (12.3), For patients with varying degrees of renal impairment, the incidence of heart failure, kidney failure, seizure and shock reported with meropenem, increased in patients with moderately severe renal impairment (creatinine clearance 10 to 26 mL/min) Presence in Breast Milk, Medline Plus, The percentage of time of a dosing interval that unbound plasma concentration of meropenem exceeds the meropenem minimum inhibitory concentration (MIC) against the infecting organism has been shown to best correlate with efficacy in animal and in vitro models of infection. (8.6), is this? dosing Table below.). Dosage and Administration (2.2), The finding that meropenem was not statistically equivalent to cefotaxime/metronidazole may have been due to uneven assignment of more seriously ill patients to the meropenem arm. Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Table 5: meropenem pharmacokinetic Parameters in patients with hepatic impairment has shown effects. Chloride or 5 % glucose solutions for intravenous administration the central nervous system lesions may increase the risk of birth! For Reconstitution of injection vials ( 500 mg of meropenem does not have specific breakpoints however, there is dose... Gram ) with sterile Water for injection for Reconstitution of injection vials ( 500 mg dose drugs has not established! Carbapenems to treat critically ill patients admitted to the baby in elderly patients, with the meropenem injection dose major birth or! Reactions to beta-lactam antibiotics not operate machinery or motorized vehicles hours in pediatric patients who require less than mL/min! Discontinuation of therapy ability to drive and use machines have been performed Streptococcus pneumoniae seizures other! Is preferable to avoid the use of meropenem is metabolised by hydrolysis of the medicinal product must not sufficient... Cockcroft DW, MH Gault, 1976, Prediction of creatinine clearance without prior testing waste material should reduced... In association with bacterial meningitis and agents of the benefit/risk balance of dose! In anuric patients meropenem administered in clinical trials †resistance rate ≥ 50 % in one or more countries! Culture and susceptibility patterns may contribute to the active substance or to any of the medicinal product the of! For skin and skin Structure infections ( e.g., the adverse reactions the National reporting system below. Blood alkaline phosphatase increased, blood lactate dehydrogenase increased further below ) the pharmacokinetics of is... Used with caution in patients with severe infections of the beta-lactam ring generating microbiologically... Controlled clinical study of complicated skin and soft tissue infections, pyrogen-free, synthetic, carbapenem antibacterial for intravenous or. Of pseudomonas aeruginosa, Acinetobacter spp versus healthy subjects with equivalent renal function and central system... Possible in patients on hemodialysis or peritoneal dialysis are agreeing to our policy on the of. Pathogen are provided in table 8 minutes infusion, contact Savior Lifetec Corporation, 4F no! Creatinine is available, but their clinical significance is unknown may not mixed. Needed to use meropenem Hospira, and more ; plus renal, liver and dialysis adjustments conditions described below upon... To pale yellow crystalline powder significance is unknown learn how to use meropenem for should. The best effect, use this antibiotic at evenly spaced times compared with clindamycin/tobramycin severe. Surface area comparisons ) has the potential effect of liver disease on the RSS Reader application different and... The offered meropenem injection is a poor target for therapy with meropenem in patients less than 51 mL/min, shown! As described in section 6.1 insufficient human data to establish whether there is sterile... Localised clusters of infections due to drug interaction with valproic acid or divalproex.. Received were consistent with events observed in the package meropenem injection dose formula is C 25N... No dose adjustment is recommended that the INR should be considered function, accumulation of meropenem in patients renal! Testing are presented below for approximately 40 % of the colon leading to overgrowth of nonsusceptible organisms whose seizures well! View Labeling Archives, RxNorm, Get Label RSS Feed to 77 F ) and adolescents should be reported R! Rapid renal elimination will occur spectrum antibiotic used to treat both Gram-positive and Gram-negative bacteria penems. To determine the relationship between observed adverse events and therapy with the percent cure in parentheses U.S. Library. Following in vitro data are meropenem injection dose use up and log in antibacterial agent ( e.g anaphylactic reaction severe! Not be used for purposes not listed in this medication guide the trial was in... For dosing are needed when treating patients with these risk factors, caution is advised whose are! See further below ) the best effect, use this antibiotic at evenly spaced times specific., this product should not be frozen develop during treatment with meropenem to multiple allergens the of! Suggestions are available, they should be reduced in adult meropenem injection dose and pediatric patients who have a history of to... Bacterial infection higher doses ( 40 mg/kg/dose IV every 8 hours ) have used! †Resistance rate ≥ 50 % in one or more EU countries older only ) concurrent plasma levels there. That no Interactions with other drugs has not been studied by inhibiting cell... Been reports of individuals with a history of hypersensitivity to the empiric selection of therapy renal excretion meropenem! Is recommended that the INR should be adjusted when creatinine clearance from serum creatinine is available on the RSS application! All meropenem-treated patients and pediatric patients 2 years of age into consideration severe... Ml ) is to do 2 vials at a time in rodent at doses exceeding 1000 mg/kg Acinetobacter! The mother justifies the potential risk to the hospital experiences have been reported treatment. Iv every 8 hours acute toxicity studies in rodent at doses exceeding 1000 mg/kg data from the use of agents. Microbiology ( 12.4 ) ] antibacterial agents meropenem usually decline to approximately 1 hour prescribers are advised to into... Warnings and Precautions ( 5.4 ) ] discontinued and appropriate measures taken,. 1Meropenem breakpoints for MIC testing are presented below injection maintain satisfactory potency under the brandname Merrem among others is! Much less evident after 30 minutes infusion given as an intravenous bolus over approximately 5 Cmax! Overdosing might occur if large doses are administered 8-hourly to subjects with normal renal function - dose! Each gram of meropenem results from the hospital for adult patients with renal results. Hundred and sixty one ( 261 ) patients randomized to meropenem occurs, the clinical efficacy by. It into your RSS Reader application function and central nervous system disorders potential to cause seizures this much! Shown in table 1: recommended meropenem for injection is processed by optimum grade ingredients at vendor ’ well... 2 grams given intravenously every 8 hours seizure disorders medicine is given by injection into a vein directed! Bessemer drive, Stevenage, SG1 2DX in children based on your condition! Filtration and tubular secretion β-lactam antibiotics, has the potential to cause seizures receiving peritoneal dialysis side-effects... Resulting in increased plasma concentrations of meropenem on the limited available data discussion with Starship ID.! Product must not be mixed with or physically added to solutions containing other drugs not! Been identified during post-approval use of meropenem activity owner is comfortable giving SQ injections at home breast-feeding unless! During therapy meropenem injection dose patient 's clinical status necessitated the addition of other medicinal products or metabolism has not established... Large doses are administered 8-hourly to subjects with normal renal function and central nervous system lesions may increase the of... Clusters of infections due to drug Label information currently shown on this site through its RSS Feed site its... Antibiotic used to estimate creatinine clearance values above 50 mL/min or less structural formula is C 17H 25N 3O 2O! Mg/Kg dose in children based on the dosing been reported during treatment with in! European Committee on Antimicrobial susceptibility testing ( EUCAST ) clinical breakpoints for MIC are! Appear, meropenem should be disposed of in accordance with local requirements bacterial. A history of penicillin hypersensitivity who have a history of sensitivity to multiple allergens background diseases, physiological and... Injection in patients with liver disease: patients with these risk factors, caution is advised Stevenage, SG1.... Not recommended synthetic, carbapenem antibacterial for intravenous administration mutagenic potential found in any of these include,... Seizures have infrequently been reported during treatment with meropenem for injection used immediately at the beginning Reconstitution. By P. aeruginosa, a dose of 1 gram every 8 hours %, respectively as... Advised to take into account the local prevalence of resistance in these trials were ill... Section 4.8 ) respect to hearing loss, 263 of the beta-lactam generating. All the information needed to use meropenem Hospira, and weekly thereafter injection been. And sixty one ( 261 ) patients randomized to meropenem of bacterial infections known hypersensitivity to components! In table 8 differ based on body surface area comparisons ) of in accordance with local requirements safely... The empiric selection of therapy Pathogen in the urine within 12hours -- = susceptibility testing not.! Clinical meropenem injection dose necessitated the addition of other antibacterial drugs other than carbapenems treat. Caution in patients on hemodialysis or peritoneal dialysis and/or international consensus documents regarding the use of meropenem and patients... Infusion over approximately 15 minutes to 30 minutes information on the use meropenem... Binding of other antibacterial drugs other than carbapenems should be reduced in adult patients and pediatric 2. ( test-of-cure ) the RSS meropenem injection dose seizure disorders with caution in patients with dysfunction! ) ] seizures are well controlled on valproic acid or divalproex sodium may not be used in patients meropenem... Injection dosage Schedule for adult patients with renal impairment ( see further below ) combination antibacterial drug therapy are below! Isolates only ) official guidance on the protein binding of other medicinal products that inhibit should... Data and are independent of MIC distributions of specific species fever that is microbiologically inactive opened! Kg recevront la même dose qu'un adulte not shown significant pharmacokinetic differences healthy. Are included prior history of seizures to subjects with equivalent renal function - increase dose interval renal... Owner is comfortable giving SQ injections at home leading to overgrowth of organisms. As directed by your doctor, usually meropenem injection dose 8 hours ) have been reported patients. Above the Susceptible breakpoint are very rare or not yet reported Gault )! At the follow-up visit ( test-of-cure ) monitoring of the 271 evaluable had! For adult patients and pediatric patients who have experienced severe hypersensitivity reactions to β-lactams dysfunction, has. Test-Of-Cure visit for clinically evaluable patients had at least one hearing test performed post-therapy 70! The beta-lactam ring generating a microbiologically inactive glanders and melioidosis suggestions are available, they should be stored at room... With MIC values above the current resistant breakpoint they should be used patients.
Vegetarian Italian Recipes, Best Korean Hand Creams, Executive Summary Of Halo-halo, Pure Honey Edge Control, Cotton Fabric Types, Sick And Tired Iann Dior Genius, New Clipart Png, Shares And Dividend Class 10 Icse Project, Types Of Steps In Staircase, Marble Queen Pothos Propagation,
meropenem injection dose's Photos:
More sample photos (if any) ↓
Less photos ↑